Market cap
$8.717 B
$42.30 +1.37%
Close of 7 Aug 2026
Revenue
$2.09B
#1118 by revenue
Earnings
$424.9M
#685 by earnings
Shares outstanding
216,920,735
Latest filing cover page
P/E ratio
20.5
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap
All 160 →Where these numbers come from
Share counts and financials for Qiagen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.